Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
V5E8dy6sb9mTUsmj